Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-02 7:50 pm | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 2,500 | $49 | $122,500 | 29,127 (Direct) | View |
| 2024-09-17 Sale | 2024-09-17 6:20 pm | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 13,500 | $48.28 | $651,766 | 38,627 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 9:02 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $20.01 | $113,214 | 435,802 (Direct) | View |
| 2023-08-22 Sale | 2023-08-24 8:30 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 18,600 | $20.01 | $372,186 | 390,877 (Direct) | View |
| 2023-08-11 Sale | 2023-08-15 8:30 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $20 | $28,000 | 368,727 (Direct) | View |
| 2023-07-10 Sale | 2023-07-11 9:00 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 20,000 | $21.58 | $431,541 | 410,877 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:31 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,966 | $18.05 | $107,686 | 263,436 (Direct) | View |
| 2022-12-09 Sale | 2022-12-13 8:01 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 15,000 | $25.03 | $375,450 | 265,605 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 7:03 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 3,507 | $14.59 | $51,167 | 229,402 (Direct) | View |
| 2021-08-04 Sale | 2021-08-06 9:01 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 30,000 | $35.08 | $1,052,322 | 327,459 (Direct) | View |
| 2021-07-20 Sale | 2021-07-22 9:01 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 17,400 | $33.14 | $576,575 | 325,103 (Direct) | View |
| 2021-07-15 Sale | 2021-07-19 9:02 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 4,600 | $33.37 | $153,502 | 278,762 (Direct) | View |
| 2021-01-14 Sale(A) | 2021-07-19 9:02 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $43.99 | $2,419,344 | 436,330 (Direct) | View |
| 2021-01-14 Sale | 2021-01-19 9:50 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $43.99 | $2,419,344 | 436,330 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 6:05 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 16,000 | $32.9 | $526,410 | 240,903 (Direct) | View |
| 2020-08-31 Sale | 2020-09-01 5:13 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $27.05 | $135,250 | 256,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Exercise | 2024-12-02 7:50 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 2,500 | $0 | 29,127 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-02 7:50 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 2,500 | $29.55 | 29,127 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 13,500 | $0 | 38,627 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 5,000 | $14.18 | 38,627 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 8,500 | $29.55 | 38,627 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 9:02 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $0 | 435,802 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 9:02 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $3.3 | 435,802 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 18,600 | $0 | 390,877 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $15.5 | 390,877 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 13,600 | $3.3 | 390,877 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-15 8:30 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $0 | 368,727 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-15 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $3.3 | 368,727 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 20,000 | $0 | 410,877 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $15.5 | 410,877 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 15,000 | $3.3 | 410,877 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:02 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 100,000 | $0 | 329,402 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 8:01 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 15,000 | $0 | 265,605 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 8:01 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 15,000 | $1.01 | 265,605 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:06 pm | N/A 2032-06-14 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:15 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 56,875 | $0 | 267,034 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 9:01 pm | N/A 2029-04-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 30,000 | $0 | 327,459 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 9:01 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 30,000 | $15.5 | 327,459 (Direct) | View |
| 2021-07-20 Exercise | 2021-07-22 9:01 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 17,400 | $0 | 325,103 (Direct) | View |
| 2021-07-20 Exercise | 2021-07-22 9:01 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 17,400 | $1.01 | 325,103 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-19 9:02 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 4,600 | $0 | 278,762 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-19 9:02 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 4,600 | $1.01 | 278,762 (Direct) | View |
| 2021-01-14 Exercise(A) | 2021-07-19 9:02 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $0 | 436,330 (Direct) | View |
| 2021-01-14 Exercise(A) | 2021-07-19 9:02 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $1.01 | 436,330 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:50 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 20,063 | $0 | 20,063 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:20 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 85,415 | $0 | 261,409 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-19 9:50 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $0 | 436,330 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-19 9:50 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 55,000 | $1.01 | 436,330 (Direct) | View |
| 2020-12-23 Exercise | 2020-12-28 9:01 pm | N/A 2026-03-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 50,704 | $0 | 208,752 (Direct) | View |
| 2020-12-23 Exercise | 2020-12-28 9:01 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 50,704 | $1.75 | 208,752 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 9:35 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 12,590 | $0 | 246,981 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 9:35 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 12,590 | $3.3 | 246,981 (Direct) | View |
| 2020-10-14 Exercise | 2020-10-16 6:05 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 16,000 | $0 | 240,903 (Direct) | View |
| 2020-10-14 Exercise | 2020-10-16 6:05 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 16,000 | $1.01 | 240,903 (Direct) | View |
| 2020-09-04 Option Award | 2020-09-09 4:51 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-31 Exercise | 2020-09-01 5:13 pm | N/A 2025-11-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $0 | 256,903 (Direct) | View |
| 2020-08-31 Exercise | 2020-09-01 5:13 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $1.01 | 256,903 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-02 4:35 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 85,450 | $0 | 85,450 (Direct) | View |